All entries for: Veloxis Pharmaceuticals

March 15, 2026

Veloxis Pharmaceuticals

Orphan Drug Designation

prophylaxis of heart allograft rejection in patients receiving a heart transplant

Disease Area: Rare Diseases
December 23, 2025

Veloxis Pharmaceuticals

Orphan Drug Designation

FDA orphan drug designation: prevention of organ rejection in patients receiving a liver transplant

Disease Area: Rare Diseases
Scroll to Top